Olympia Compounding Pharmacy dba Olympia Pharmacy recalls NAD+ Nicotinamide Adenine Dinucleotide, Lyophilized powder for reconstitution, Multi-Dose 500 mg per vial, Each ML conta
Recalled March 30, 2022 · FDA recall D-0719-2022 · Olympia Compounding Pharmacy
Hazard
Product found to be Sub Potent or Exceeded reconstitution time · FDA Class II
Units
2634 vials
Sold at
Nationwide in the USA including Puerto Rico.
Description
Product found to be Sub Potent or Exceeded reconstitution time
Product
NAD+ Nicotinamide Adenine Dinucleotide, Lyophilized powder for reconstitution, Multi-Dose 500 mg per vial, Each ML contains: 0.288% Sodium Phosphate Monobasic USP, 0.42% Sodium Phosphate Dibasic USP, 5% Mannitol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals 6700 Conroy Rd., Ste. 155, Orlando, FL 32835 NDC: 73198-0083-00
Manufacturer(s)
Olympia Compounding Pharmacy dba Olympia Pharmacy
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →